Deutsche Bank Starts Coverage on Large Biotechs; DNA, GILD & AMGN Rated Buys, BIIB & GENZ Rated Holds
More News related to AMGN
- Amgen and Wyeth Statement on the FDA Safety Announcement Regarding Tumor Necrosis Factor (TNF) Blockers
- BeaconEquity.com Issues Technical Trade Alerts on BioPharmaceutical Stocks: CEGE, AMLN, DNA, GENZ, AMGN, GILD
- Amgen (AMGN) to Halt Discounts on Aranesp -NYTimes
- FDA Approves Amgen's (AMGN) Nplate(TM) for Adult Chronic ITP
- FDA Approves Nplate(TM) for Long-Term Treatment of Adult Chronic ITP
More News related to BIIB
- Elan and Biogen Idec Initiate First Clinical Trial of TYSABRI(R) in Oncology
- Biogen Idec to Present at the 3rd Annual CITI Biotech Day
- Morgan Stanley Starts Elan (ELN) at Overweight
- Biogen Idec to Present at the Thomas Weisel Partners Healthcare Conference
- Deutsche Bank Notes Tysabri PML Patients are Recovering (BIIB, ELN)
More News related to DNA
- BeaconEquity.com Issues Technical Trade Alerts on BioPharmaceutical Stocks: CEGE, AMLN, DNA, GENZ, AMGN, GILD
- Genentech (DNA) volatility Flat; shares trade above Roche $89 offer
- BeaconEquity.com Issues Trade Alerts on Biotechnology Stocks: ELN, PFE, AMGN, DNA, BIIB, GILD
- JANA Partners 13F Shows New Stakes in Genentech (DNA), Sears (SHLD), Washington Mutual (WM); Adds to Positions in AK Steel (AKS), Focus Media (FMCN), Transocean (RIG); Sells Out of Apple (AAPL), Lehma
- Notable Analyst Rating Changes 8/15: SPWR, PCLN, ADSK Upgraded; JNJ, JWN, DNA Downgraded
Deutsche Bank initiates coverage on a number of large biotech companies after the close:
Initiates coverage on Genentech Inc. (NYSE: DNA) at Buy rating, $83 price target.
Initiates coverage on Gilead Sciences Inc. (Nasdaq: GILD) with a Buy rating, $63 price target.
Initiates coverage on Amgen (Nasdaq: AMGN) with a Buy rating, $52 price target.
Initiates coverage on Biogen-Idec (Nasdaq: BIIB) with a Hold rating, $60 price target.
Initiates coverage on Genzyme (Nasdaq: GENZ) with a Hold rating, $73 price target.
Related Categories
New CoverageStocks Mentioned
-0.47
+0.43Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
